All Infection Prevention & Control articles – Page 12
-
NewsBovine H5N1 influenza may spread via milking
Milking practices may be linked to the transmission of bovine H5N1 influenza virus, which affects dairy cattle and was first detected in the U.S. in spring 2024.
-
NewsPromising TB therapy safe for patients with HIV
A therapy showing promise to help control tuberculosis (TB) does not interfere with combined antiretroviral therapy (cART), according to new research.
-
NewsGraphene spike mat and fridge magnet tech team up against antibiotic resistance
Researchers have deployed the bactericidal properties of graphene by using the same technology found in an ordinary fridge magnet, resulting in an ultra-thin acupuncture-like surface that can act as a coating on catheters and implants.
-
NewsCan a drug-free nasal spray protect against deadly respiratory infections?
A novel nasal spray for preventing respiratory infections works by forming a protective coating on the nasal cavity, which captures airborne respiratory droplets and acts as a physical barrier against viruses and bacteria, while effectively neutralizing them.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsResearchers investigate bunyaviruses and picornaviruses in bid to stave off next pandemic
A $13 million per year grant will enable researchers to accelerate their investigations of bunyaviruses, which include life-threatening respiratory and hemorrhagic fever viruses, and picornaviruses, notably enterovirus D68.
-
NewsResearchers identify critical immune factor for host defense against MRSA
Researchers identify a critical immune factor for host defense against MRSA, offering a potential explanation for failures of previous vaccine strategies and a proposal for a new direction for tackling this bacterium.
-
NewsResearchers to study how much MRSA is lurking in the air in hospitals
Scientists are working to minimize health care workers’ exposure to MRSA, or methicillin-resistant Staphylococcus aureus, a type of staph bacteria that’s become resistant to many of the antibiotics used to treat ordinary staph infections.
-
NewsMonoclonal antibodies offer hope for tackling antimicrobial resistance
Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of antimicrobial resistance, say scientists.
-
NewsWyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic
The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.
-
NewsSome guidelines for diagnosis and treatment of hepatitis E virus infection need a revamp, evaluation finds
A systematic evaluation of HEV infection guidelines revealed significant variability in their quality and recommendations. While some demonstrated strengths, others were found lacking in stakeholder involvement, rigor of development, and applicability.
-
NewsTriple antibody therapy shows promise for long-lasting HIV control
A cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV, a new study shows. Some participants showed long-term control of the virus months after antibody levels declined to low or undetectable.
-
NewsNewly discovered antimicrobial could prevent or treat cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection. A study identifies the first known microcin that targets the strains of bacteria that cause cholera.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsTiny heroes and innovative technology can fight back against antibiotic-resistant biofilms
Researchers show that antibiotic-infused silver nanoparticles can effectively break down biofilms and also unveil a new sensing method to assess antimicrobial activity.
-
NewsInnovative implant material combines osteogenic and antibacterial properties for superior bone repair
A new study introduces a novel polyetheretherketone (PEEK)-based implant material that not only promotes bone growth but also possesses potent antibacterial capabilities.
-
NewsStudy on E. coli outbreak in the UK demonstrates increasing impact of climate change on public health and food security
A study to investigate an UK E. coli outbreak identified contaminated lettuce as the most likely source of the infection, and determined that heavy rainfall and flooding may have carried STEC from animal feces to the lettuce crops.
-
NewsResearchers discover an effective and environment-friendly disinfectant
Researchers have discovered a promising alternative to chloroxylenol that works more effectively in combating certain common bacteria, fungi and viruses, and can be rapidly degraded and detoxified in receiving waters.
-
NewsFirst sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. ...
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.